Literature DB >> 22103585

Bacteremia and MR-proANP changes in mild community-acquired pneumonia.

Solweig Guinard-Barbier1, Camille Chenevier-Gobeaux, Sophie Grabar, Laurent Quinquis, Jeannot Schmidt, Pierre Hausfater, Enrique Casalino, Stéphanie Huet, Jean-Louis Pourriat, Bertrand Renaud, Yann-Erick Claessens.   

Abstract

BACKGROUND: Mid-regional pro-atrial natriuretic peptide (MR-proANP) increases with severity in community-acquired pneumonia (CAP). We investigated whether changes of MR-proANP correlated to bacteremia.
METHODS: 392 adult patients with CAP visiting emergency department from a prospective observational multicenter study.
RESULTS: MR-proANP levels increased in patients with positive bacteremia (92.8 pmol/L vs. 84.3 pmol/L, p = 0.04). Performance of MR-proANP to detect bacteremia (0.60) was equivalent to CRP (0.59) but less accurate than PCT (0.69).
CONCLUSION: MR-ANP poorly predicts bacteremia in CAP patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22103585     DOI: 10.3109/1354750X.2011.620629

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  2 in total

1.  Sensitivity and Specificity of Soluble Triggering Receptor Expressed on Myeloid Cells-1, Midregional Proatrial Natriuretic Peptide and Midregional Proadrenomedullin for Distinguishing Etiology and to Assess Severity in Community-Acquired Pneumonia.

Authors:  Susanna Esposito; Maria Di Gangi; Fabio Cardinale; Eugenio Baraldi; Ilaria Corsini; Liviana Da Dalt; Pier Angelo Tovo; Antonio Correra; Alberto Villani; Oliviero Sacco; Laura Tenero; Piera Dones; Monia Gambino; Alberto Zampiero; Nicola Principi
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

2.  A pilot study on the diagnostic accuracy of proadrenomedullin and proatrial natriuretic Peptide in lower respiratory tract infections.

Authors:  Agustín Ruiz-González; Aureli Esquerda; José M Porcel; Silvia Bielsa; Horacio Valencia; Gonzalo Cao; Miquel Falguera
Journal:  Open Respir Med J       Date:  2014-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.